FDA approves Cellfina System for cellulite removal- Ulthera Inc.
Ulthera, Inc. a wholly-owned subsidiary of Merz, Inc. (US affiliate of the global Merz Pharma Group), announced that the FDA has cleared its Cellfina System for the long-term improvement in the appearance of cellulite on the buttocks and thighs with no loss of benefit for up to 2 years.
Cellfina is the only FDA-cleared minimally invasive procedure clinically proven to improve the appearance of cellulite for results that last at least two years, the longest duration cleared by the FDA.
The Cellfina System will be available to physicians across the U.S. in Fall 2015.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.